INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 45h ago
HOUSE PTR5h ago
SEC 13F5h ago
ROBINHOOD CHAIN5h ago
Corporate insider
SB

Schimmelpennink Evert B.

Director, President, CEO and SecretaryCIK 0001713795

EDGAR filingsOpen in network
Disclosed transactions2
Buys / sells1 / 0
Max Insider Score57
Connections2with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
9
SB
Schimmelpennink Evert B.Director
CTNMContineum Therapeutics, Inc.
Grant or award
A—
19.0K sh
Jun 26, 2026Jun 26, 2026
traded Jun 26, 2026
+0dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Contineum Therapeutics, Inc.Director · Jun 26, 2026
  • Insider ofevidence
    LENZ Therapeutics, Inc.Director, President, CEO and Secretary · Mar 30, 2026
57
SB
Schimmelpennink Evert B.Director, President, CEO and Secretary
LENZLENZ Therapeutics, Inc.
Open-market purchase
BUY
$251K
28.1K sh
Mar 27, 2026
Mar 30, 2026
traded Mar 27, 2026
+3d
SEC FORM 4

Evidence